Clinical Report: Patterns of Spread in Ocular Melanoma
Overview
A retrospective study of 167 patients with conjunctival malignant melanoma revealed that 25% developed metastatic disease over a mean follow-up of 78 months. Tumor location and stage significantly influenced metastatic risk, with cT2 tumors showing higher rates of spread compared to cT1 tumors.
Background
Ocular melanoma, particularly conjunctival melanoma, poses significant treatment challenges due to its potential for metastasis. Understanding the patterns of spread is crucial for improving patient outcomes and guiding surveillance strategies. This study provides insights into the relationship between tumor characteristics and metastatic progression.
Data Highlights
Finding
Value
Mean follow-up duration
78 months
Local recurrence rate
47%
Metastatic disease rate
25%
Mean time to regional lymph node metastasis
49 months
Mean time to distant metastasis
56 months
Key Findings
25% of patients developed metastases during long-term follow-up.
Local recurrence occurred in 47% of patients at a mean of 42 months.
cT2 tumors were associated with higher metastatic risk compared to cT1 tumors.
Adjuvant therapy reduced the risk of systemic spread in pT1 tumors.
Ruthenium-106 brachytherapy was linked to lower rates of hematogenous metastasis.
Patterns of spread followed a sequential course, with local recurrence strongly associated with distant metastasis.
Clinical Implications
Discuss the benefits of adjuvant therapy in pT1 tumors to mitigate systemic spread.
Conclusion
This study enhances the understanding of metastatic patterns in conjunctival melanoma, providing a foundation for improved risk stratification and management strategies in affected patients.
